TABLE 1. RAPID GROWTH SCENARIO OF POTENTIAL ZIKA VIRUS VACCINES MARKET, BY GEOGRAPHY, 2017-2022 ($MILLION)
TABLE 2. MODERATE GROWTH SCENARIO OF POTENTIAL ZIKA VIRUS VACCINES MARKET, BY GEOGRAPHY, 2017-2022 ($MILLION)
TABLE 3. LOW GROWTH SCENARIO OF POTENTIAL ZIKA VIRUS VACCINES MARKET, BY GEOGRAPHY, 2017-2022 ($MILLION)
TABLE 4. NORTH AMERICA: POTENTIAL ANALYSIS OF ZIKA VIRUS VACCINES MARKET, ($MILLION), 2017-2022
TABLE 5. EUROPE: POTENTIAL ANALYSIS OF ZIKA VIRUS VACCINES MARKET, ($MILLION), 2017-2022
TABLE 6. ASIA-PACIFIC: POTENTIAL ANALYSIS OF ZIKA VIRUS VACCINES MARKET, ($MILLION), 2017-2022
TABLE 7. LAMEA: POTENTIAL ANALYSIS OF ZIKA VIRUS VACCINES MARKET, ($MILLION), 2017-2022
TABLE 8. BRAZIL: POTENTIAL ANALYSIS OF ZIKA VIRUS VACCINES MARKET, ($MILLION), 2017-2022
TABLE 9. MEXICO: POTENTIAL ANALYSIS OF ZIKA VIRUS VACCINES MARKET, ($MILLION), 2017-2022
TABLE 10. PHILIPPINES: POTENTIAL ANALYSIS OF ZIKA VIRUS VACCINES MARKET, ($MILLION), 2017-2022
TABLE 11. VIETNAM: POTENTIAL ANALYSIS OF ZIKA VIRUS VACCINES MARKET, ($MILLION), 2017-2022
TABLE 12. THAILAND: POTENTIAL ANALYSIS OF ZIKA VIRUS VACCINES MARKET, ($MILLION), 2017-2022
TABLE 13. REST OF THE WORLD: POTENTIAL ANALYSIS OF ZIKA VIRUS VACCINES MARKET, ($MILLION), 2017-2022
TABLE 14. BHARAT BIOTECH INTERNATIONAL LIMITED: COMPANY SNAPSHOT
TABLE 15. BHARAT BIOTECH INTERNATIONAL LIMITED: OPERATING SEGMENTS
TABLE 16. GENEONE LIFE SCIENCE INC.: COMPANY SNAPSHOT
TABLE 17. GLAXOSMITHKLINE PLC.: COMPANY SNAPSHOT
TABLE 18. GLAXOSMITHKLINE PLC.: OPERATING SEGMENTS
TABLE 19. HAWAII BIOTECH INC.: COMPANY SNAPSHOT
TABLE 20. HAWAII BIOTECH INC.: OPERATING SEGMENTS
TABLE 21. IMMUNOVACCINE INC.: COMPANY SNAPSHOT
TABLE 22. INOVIO PHARMACEUTICALS, INC.: COMPANY SNAPSHOT
TABLE 23. NEWLINK GENETICS: COMPANY SNAPSHOT
TABLE 24. SANOFI S.A.: COMPANY SNAPSHOT
TABLE 25. SANOFI S.A.: OPERATING SEGMENTS
TABLE 26. TAKEDA PHARMACEUTICAL COMPANY LIMITED: COMPANY SNAPSHOT
TABLE 27. TAKEDA PHARMACEUTICAL COMPANY LIMITED: OPERATING SEGMENTS

LIST OF FIGURE

FIGURE 1. ZIKA VIRUS VACCINES MARKET SEGMENTATION
FIGURE 2. NUMBER OF COUNTRIES AND TERRITORIES REPORTING MOSQUITO-BORNE ZIKA VIRUS TRANSMISSION AS OF OCTOBER 27, 2016, BY REGION
FIGURE 3. RISK OF ZIKA VIRUS INFECTION DUE TO TRAVELERS FROM BRAZIL TO SPECIFIC COUNTRIES
FIGURE 4. FLOWCHART OF VACCINE APPROVAL
FIGURE 5. NUMBER OF ZIKA VIRUS INFECTION CASES IN LATIN AMERICA BY COUNTRY
FIGURE 6. NUMBER OF COUNTRIES & TERRITORIES REPORTING MOSQUITO-BORNE ZIKA VIRUS INFECTION BY REGION
FIGURE 7. TIMELINE OF SPREAD FOR ZIKA VIRUS
FIGURE 8. NUMBER OF LABORATORY-CONFIRMED ZIKA VIRUS INFECTION CASES IN U.S., AS OF NOVEMBER 2016
FIGURE 9. REPORTED TRAVEL-ASSOCIATED CASES OF ZIKA VIRUS IN BRITISH POPULATION, BY COUNTRY
FIGURE 10. GLAXOSMITHKLINE PLC.: REVENUE ($MILLION), 2013-2015
FIGURE 11. GLAXOSMITHKLINE PLC.: BY PRINCIPLE PRODUCT CATEGORY, 2015%
FIGURE 12. GSK: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 13. IMMUNOVACCINE INC.: REVENUE ($MILLION), 2013-2015
FIGURE 14. INOVIO PHARMACEUTICALS, INC.: REVENUE ($MILLION), 2013-2015
FIGURE 15. NEWLINK GENETICS: REVENUE ($MILLION), 2013-2015 85
FIGURE 16. SANOFI S.A.: REVENUE ($MILLION), 2013-2015
FIGURE 17. SANOFI S.A.: BY PRINCIPLE PRODUCT CATEGORY, 2015%
FIGURE 18. SANOFI S.A.: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 19. TAKEDA PHARMACEUTICAL COMPANY LIMITED: REVENUE ($MILLION), 2013-2015